Fri, March 31, 2017

[ Fri, Mar 31st 2017 ]: WOPRAI

Kevin Choquette Upgraded (CM) to Hold on, Mar 31st, 2017

Thu, March 30, 2017

[ Thu, Mar 30th 2017 ]: WOPRAI

DTRM SqueezeTrigger Price is $2.10. There is $85,008 That Short Sellers Still Need To Cover.

[ Thu, Mar 30th 2017 ]: WOPRAI

Gevo Inc. (NASDAQ:GEVO), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Report

[ Thu, Mar 30th 2017 ]: WOPRAI

Ardelyx (NASDAQ:ARDX), Down After BUYINS.NET Report Predicted Stock Would Go Down Due To Conditions Outlined In Our Report

[ Thu, Mar 30th 2017 ]: WOPRAI

DryShips Inc. (NASDAQ:DRYS), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Report

[ Thu, Mar 30th 2017 ]: WOPRAI

AngioDynamics Inc. (NASDAQ:ANGO), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our Repo

[ Thu, Mar 30th 2017 ]: WOPRAI

Alliance Resource Partners L.P. (NASDAQ:ARLP), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outline

[ Thu, Mar 30th 2017 ]: WOPRAI

Bonso Electronics International, Inc. (NASDAQ:BNSO), Up By $0.16 (6.73%) After BUYINS.NET SqueezeTrigger Report Released on Wed

[ Thu, Mar 30th 2017 ]: WOPRAI

Videocon d2h Shs American Deposit Share Repr 4 Shs (NASDAQ:VDTH), Up By $2.57 (28.65%) After BUYINS.NET SqueezeTrigger Report R

[ Thu, Mar 30th 2017 ]: WOPRAI

iShares Dow Jones U.S. Oil & Gas Exploration & Production Index Fund (NYSE:IEO), Up After BUYINS.NET Report Predicted Stock Wou

[ Thu, Mar 30th 2017 ]: WOPRAI

Osiris Therapeutics Inc. (PINK:OSIR), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our

[ Thu, Mar 30th 2017 ]: WOPRAI

OSTK, VGR, BLUE, VICL, CUZ, JWN, Expected to Trade Lower After Bearish Insider Trading

[ Thu, Mar 30th 2017 ]: WOPRAI

ILMN, KOPN, ATRA, SEDG, Expected to Trade Lower After Bearish Insider Trading

[ Thu, Mar 30th 2017 ]: WOPRAI

KFS, Expected to Trade Higher After Bullish Insider Trading

[ Thu, Mar 30th 2017 ]: WOPRAI

GVI, CSJ, CIU, HYG, BSV, PAR Are Seasonally Ripe To Go Down In the Next Five Weeks

[ Thu, Mar 30th 2017 ]: WOPRAI

NYMT, SHY Are Seasonally Ripe To Go Down In the Next Five Weeks

[ Thu, Mar 30th 2017 ]: WOPRAI

Brian Alger Upgraded (APPS) to Strong Buy on, Mar 30th, 2017

[ Thu, Mar 30th 2017 ]: WOPRAI

Martin Auster Initiated (UTHR) at Strong Sell and Held Target at $112 on, Mar 30th, 2017

[ Thu, Mar 30th 2017 ]: WOPRAI

Esther Rajavelu Initiated (ALNY) at Hold and Held Target at $55 on, Mar 30th, 2017

[ Thu, Mar 30th 2017 ]: WOPRAI

Martin Auster Initiated (BMRN) at Hold and Held Target at $92 on, Mar 30th, 2017

[ Thu, Mar 30th 2017 ]: WOPRAI

Scott Schrier Initiated (VMC) at Strong Buy on, Mar 30th, 2017

[ Thu, Mar 30th 2017 ]: WOPRAI

John Quealy Initiated (WLDN) at Strong Buy and Held Target at $36 on, Mar 30th, 2017

Wed, March 29, 2017

[ Wed, Mar 29th 2017 ]: WOPRAI

Laurence Alexander Upgraded (CC) to Strong Buy and Increased Target to $48 on, Mar 29th, 2017

[ Wed, Mar 29th 2017 ]: WOPRAI

Do Kim Upgraded (VRTX) to Buy on, Mar 29th, 2017

[ Wed, Mar 29th 2017 ]: WOPRAI

Jason Harbes Initiated (SYF) at Buy on, Mar 29th, 2017

[ Wed, Mar 29th 2017 ]: WOPRAI

Andrew Gollan Initiated (BA) at Strong Buy and Held Target at $202 on, Mar 29th, 2017

[ Wed, Mar 29th 2017 ]: WOPRAI

Scott Valentin Upgraded (ZION) to Strong Buy on, Mar 29th, 2017

[ Wed, Mar 29th 2017 ]: WOPRAI

John Bridges Upgraded (AEM) to Buy on, Mar 29th, 2017

Tue, March 28, 2017

[ Tue, Mar 28th 2017 ]: WOPRAI

CRISPR Therapeutics (NASDAQ:CRSP), Up By $1.92 (10.63%) After BUYINS.NET SqueezeTrigger Report Released on Friday, March 24th 2

[ Tue, Mar 28th 2017 ]: WOPRAI

Osiris Therapeutics Inc. (PINK:OSIR), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our

[ Tue, Mar 28th 2017 ]: WOPRAI

Access National Corporation (NASDAQ:ANCX), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In

[ Tue, Mar 28th 2017 ]: WOPRAI

Panhandle Oil and Gas Inc. (NYSE:PHX), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In Our

[ Tue, Mar 28th 2017 ]: WOPRAI

Penn National Gaming Inc. (NASDAQ:PENN), Up After BUYINS.NET Report Predicted Stock Would Go Up Due To Conditions Outlined In O

[ Tue, Mar 28th 2017 ]: WOPRAI

CBOE, MHH, ELMD, GBDC, QUAD, MORN Are Seasonally Ripe To Go Down In the Next Five Weeks

[ Tue, Mar 28th 2017 ]: WOPRAI

VRTS, EFSC Are Seasonally Ripe To Go Down In the Next Five Weeks

[ Tue, Mar 28th 2017 ]: WOPRAI

ELOS, EWA, JKI, VIG, CRI, TS Are Seasonally Ripe To Go Up In the Next Five Weeks

[ Tue, Mar 28th 2017 ]: WOPRAI

SNP, VIA, ARI, AUO, CONN, PBH Are Seasonally Ripe To Go Up In the Next Five Weeks

[ Tue, Mar 28th 2017 ]: WOPRAI

ASR, MOH, FTK, PRF, IEO, XOP Are Seasonally Ripe To Go Up In the Next Five Weeks

[ Tue, Mar 28th 2017 ]: WOPRAI

VOE, PXI, RTM, UYM, LTPZ, TIPZ Are Seasonally Ripe To Go Up In the Next Five Weeks

[ Tue, Mar 28th 2017 ]: WOPRAI

VTHR, TOWR Are Seasonally Ripe To Go Up In the Next Five Weeks

[ Tue, Mar 28th 2017 ]: WOPRAI

WOR, FUL Expected To Be Up After Next Earnings Releases

[ Tue, Mar 28th 2017 ]: WOPRAI

MCD Expected To Be Up Before Next Earnings Releases

[ Tue, Mar 28th 2017 ]: WOPRAI

SAH, FCF Expected To Be Down Before Next Earnings Releases

[ Tue, Mar 28th 2017 ]: WOPRAI

Ross Sandler Initiated (AMZN) at Buy and Held Target at $56 on, Mar 28th, 2017

[ Tue, Mar 28th 2017 ]: WOPRAI

Ross Sandler Initiated (SNAP) at Hold and Held Target at $24 on, Mar 28th, 2017

[ Tue, Mar 28th 2017 ]: WOPRAI

Blake Harper Initiated (SNAP) at Hold and Held Target at $21 on, Mar 28th, 2017

[ Tue, Mar 28th 2017 ]: WOPRAI

Gregory Zhao Initiated (WB) at Buy and Held Target at $66 on, Mar 28th, 2017

[ Tue, Mar 28th 2017 ]: WOPRAI

Deepak Mathivanan Initiated (WIX) at Buy and Held Target at $80 on, Mar 28th, 2017

Martin Auster Initiated (BMRN) at Hold and Held Target at $92 on, Mar 30th, 2017

Martin Auster of UBS, Initiated "BioMarin Pharmaceutical Inc." (BMRN) at Hold and Held Target at $92 on, Mar 30th, 2017.

Martin has made no other calls on BMRN in the last 4 months.



There are 2 other peers that have a rating on BMRN. Out of the 2 peers that are also analyzing BMRN, 0 agree with Martin's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Martin

  • Matthew Harrison of "Morgan Stanley" Initiated at Buy and Held Target at $110 on, Tuesday, February 7th, 2017
  • Kennen MacKay of "Credit Suisse" Initiated at Buy with Decreased Target to $107 on, Monday, January 23rd, 2017